Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,559 across all filing types
Latest filing 2012-05-15 Transaction in Own Shar…
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Daily share buy-back notice - Appendix 3E 2 pages 31.9KB
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including number of shares bought back, prices paid, and compliance statements. It references ASX rules and provides daily updates on the buy-back program. The document is relatively short (2577 characters) and focuses specifically on share repurchase activity rather than broader financial results or reports. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. There is no indication that this is an announcement of a report or a certification, so it is not RPA or RNS. Therefore, the correct classification is POS with high confidence.
2012-05-15 English
Daily share buy-back notice - Appendix 3E 2 pages 31.9KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including the number of shares bought back, prices paid, and compliance statements. It is a regulatory form related to the company's repurchase of its own shares. The document length is relatively short (2538 characters), and it is not a report or announcement of a report but a specific transactional disclosure. This matches the description of 'Transaction in Own Shares' filings, which report the company's buyback or sale of its own shares. Therefore, the correct classification is POS (Transaction in Own Shares).
2012-05-10 English
Daily share buy-back notice - Appendix 3E 2 pages 32.0KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including the number of shares bought back, prices paid, dates, and compliance statements. It is a regulatory form related to the company's repurchase of its own shares. The content matches the description of a 'Transaction in Own Shares' filing, which reports share repurchase activities. The document length is relatively short (2573 characters), and it is not an announcement of a report publication but the actual notice of share buy-back activity. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2012-05-09 English
Daily share buy-back notice - Appendix 3E 2 pages 31.9KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including the number of shares bought back, prices paid, dates, and compliance statements. It is a regulatory form specifically reporting transactions related to the company's repurchase of its own shares. The content matches the description of a 'Transaction in Own Shares' filing, which reports share repurchase activities. The document length is relatively short and focused solely on buy-back details, not a broader financial report or announcement. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2012-05-08 English
Daily share buy-back notice - Appendix 3E 2 pages 171.9KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a daily share buy-back notice submitted to the ASX (Australian Securities Exchange). It provides detailed information about the company's on-market share buy-back activity, including the number of shares bought back, prices paid, and compliance statements. The document is short (3245 characters) and focuses solely on reporting share repurchase activity. This matches the description of 'Transaction in Own Shares' filings, which report company buybacks or sales of its own shares. There is no indication that this is a full financial report, earnings release, or regulatory announcement beyond the buy-back notice. Therefore, the correct classification is POS (Transaction in Own Shares).
2012-05-07 English
Form 484 - Change in Share Structure 6 pages 1.2MB
Regulatory Filings Classification · 100% confidence The document is a Form 484 under the Corporations Act 2001, used to notify the Australian Securities and Investments Commission (ASIC) of changes to company details such as changes in share structure, issue or cancellation of shares, and changes to the register of members. It includes sections for changes to company officeholders and share capital. The form is a regulatory filing notifying ASIC of corporate changes rather than a financial report or announcement of financial results. It is not an annual report, earnings release, or management report. It is also not a proxy statement or voting results announcement. The document is a formal regulatory notification of company details changes, fitting the definition of Regulatory Filings (RNS). The document length is substantial and contains detailed form content, not just a brief announcement or certification letter, so it is not a Report Publication Announcement or a certification-only filing. Therefore, the correct classification is Regulatory Filings (RNS).
2012-05-07 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.